Amitraz


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D001919 Bradycardia PMID:12046725; PMID:21288150; PMID:2157035
MESH:D002493 Central Nervous System Diseases PMID:21288150
MESH:D003643 Death PMID:31813703
MESH:D004283 Dog Diseases PMID:17137059
MESH:D006470 Hemorrhage PMID:17137059
MESH:D006943 Hyperglycemia PMID:12046725; PMID:21288150
MESH:D007022 Hypotension PMID:12046725; PMID:21288150; PMID:2157035
MESH:D007035 Hypothermia PMID:12046725; PMID:21288150
MESH:D007673 Kidney Cortex Necrosis PMID:17137059
MESH:D011041 Poisoning PMID:12046725; PMID:17137059; PMID:21288150; PMID:30954834
MESH:D011141 Polyuria PMID:12046725
MESH:D012131 Respiratory Insufficiency PMID:12046725; PMID:21288150
MESH:D014474 Unconsciousness PMID:12046725
MESH:D015431 Weight Loss PMID:15350676
MESH:D015877 Miosis PMID:12046725; PMID:21288150
MESH:D015878 Mydriasis PMID:21288150
MESH:D058186 Acute Kidney Injury PMID:17137059

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.